SCHEMBL4026082

SCHEMBL4026082

Cn1c(-c2sccc2NC(=O)NCc2csc(-c3ccccc3)n2)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.46
FEN1 P39748 1/20 0.46
ERCC4 Q92889 1/20 0.46
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ENPP2 Q13822 2/20 0.41
HPGD P15428 2/20 0.40
ALDH1A1 P00352 4/20 0.39
TP53 P04637 2/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032051 0.88 RAB9A (0.40) NPC1RAB9AENPP2HPGDALDH1A1
SCHEMBL4028018 0.83 ERCC1 (0.49) ERCC1FEN1ERCC4NPC1RAB9A
SCHEMBL4029613 0.83 ERCC1 (0.47) ERCC1FEN1ERCC4NPC1RAB9A
SCHEMBL4033336 0.83 ACKR3 (0.39) NPC1RAB9AENPP2HPGDALDH1A1
SCHEMBL4030887 0.81 ERCC1 (0.51) ERCC1FEN1ERCC4MEN1KMT2A
SCHEMBL4027570 0.81 ERCC1 (0.55) ERCC1FEN1ERCC4NPC1RAB9A
SCHEMBL4028016 0.78 FEN1 (0.58) ERCC1FEN1ERCC4ALDH1A1MAPT
SCHEMBL4030403 0.78 ERCC1 (0.56) ERCC1FEN1ERCC4NPC1RAB9A
SCHEMBL4027165 0.78 ERCC1 (0.51) ERCC1FEN1ERCC4MEN1KMT2A
SCHEMBL4025080 0.77 ERCC1 (0.48) ERCC1FEN1ERCC4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP claimed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US claimed
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.